Cheţa D, Manciulea M, Sântu E, Georgescu M, Perciun R, Sulica A, Mincu I
Clinic of Diabetes, Nutrition and Metabólic Disease, Bucharest, Romania.
Rom J Intern Med. 1991 Jul-Dec;29(3-4):181-7.
To extend previous observations on the quantitative changes of IgA and other serum Ig in diabetics, additional immunochemical investigations were carried out in 96 patients, 63 males and 33 females, mean age 43.5 +/- 15.7 years, 51 with type 1 (insulin-dependent) and 45 with type 2 (non-insulin-dependent) diabetes. The immunological data were correlated with the clinical-metabolic aspects. In the whole group, the IgA level was increased (144.1 +/- 57.2 I.U.). Significant differences were recorded with respect to age for IgG, to age and diabetes type for IgA, to sex for IgM. Qualitative Ig changes, reflecting disturbances of molecular structure, mainly for IgG, seldom for IgM, but never for IgA, were observed in 20% of the patients with both types of diabetes, more seldom in cases with long disease duration. The IgG with qualitative changes were purified and their functional capacity of inhibiting the natural cytotoxic activity (NK) was tested in comparison with that induced by pretreatment of the effectory cells with normal IgG. Some of these modified IgG showed a reduced capacity of inhibiting the NK activity. These data confirm the existence of certain quantitative changes of the main serum Ig in diabetics and reveal the presence of qualitative disorders of the IgG molecules, with consequences on their functionality.
为了扩展先前关于糖尿病患者IgA和其他血清免疫球蛋白定量变化的观察结果,对96例患者进行了额外的免疫化学研究,其中男性63例,女性33例,平均年龄43.5±15.7岁,1型(胰岛素依赖型)糖尿病患者51例,2型(非胰岛素依赖型)糖尿病患者45例。将免疫学数据与临床代谢方面进行关联。在整个研究组中,IgA水平升高(144.1±57.2国际单位)。IgG在年龄方面、IgA在年龄和糖尿病类型方面、IgM在性别方面均有显著差异。在20%的两种类型糖尿病患者中观察到反映分子结构紊乱的免疫球蛋白定性变化,主要是IgG,IgM较少见,IgA从未出现,病程较长的患者中这种情况更少见。对发生定性变化的IgG进行了纯化,并测试了其抑制自然细胞毒性活性(NK)的功能能力,与用正常IgG预处理效应细胞诱导的NK活性进行比较。其中一些修饰后的IgG抑制NK活性的能力降低。这些数据证实了糖尿病患者主要血清免疫球蛋白存在一定的定量变化,并揭示了IgG分子存在定性紊乱,且对其功能产生影响。